Ocular Neuromyotonia Resolved with Oxcarbazepine

Update Item Information
Identifier 20230312_nanos_posters_107
Title Ocular Neuromyotonia Resolved with Oxcarbazepine
Creator Danielle Isen; Michael Vaphiades; Lanning Kline
Affiliation (DI) (MV) (LK) University of Alabama at Birmingham
Subject Ocular Motility; Adult Strabismus with a Focus on Diplopia
Description Ocular neuromyotonia is a disorder characterized by tonic contraction of one or more extraocular muscles. The pathophysiology is incompletely understood but thought to be due to damaged myelin sheath in ocular motor nerves, triggering crosstalk between adjacent axons, and subsequent prolonged electrical activity. Ocular neuromyotonia may be overlooked since the diagnosis requires examination of the sustained function of individual muscles. The condition usually improves with carbamazepine, but the side effect profile is often poorly tolerated. This case of ocular neuromyotonia is unique because it is one of few where oxcarbazepine was administered.
Date 2023-03-14
Language eng
Format application/pdf
Type Text
Source 2023 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2023: Poster Session I: Ocular Motility Disorders and Nystagmus
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2023. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s690krp4
Setname ehsl_novel_nam
ID 2335313
Reference URL https://collections.lib.utah.edu/ark:/87278/s690krp4
Back to Search Results